September 27, 2023
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas

Lantern Pharma (Nasdaq: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for LP-284. LP-284 is being developed for the treatment of relapsed or refractory non-Hodgkin’s lymphoma (NHL), including mantle cell lymphoma (MCL) and double hit lymphoma (DHL) and other high-grade B-cell lymphomas (HGBL). Lantern expects to commence enrollment of patients for the first-in-human Phase 1 trial for LP-284 during the fourth quarter of 2023.

For more information, visit www.lanternpharma.com

 
See More Info
 
 
 

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

BullFrog AI (Nasdaq: BFRG), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the launch of BullFrog Data Networks, a purpose-built, comprehensive data network platform that evaluates high-dimension, multi-modal data in specific disease indications to produce a customized, visual representation of previously unknown relationships and pathways. The inaugural BullFrog Data Network leverages a leading pan-cancer genomics dataset with over 10,000 primary cancer and normal samples including genomic, transcriptomic, and proteomic data.

 
Learn More
   

American Resources Corporation's ReElement Technologies Secures $46 Million in Local Incentives for Lithium-Ion Battery and Rare Earth Element Recycling Campus

American Resources’ (Nasdaq: AREC), wholly owned subsidiary, ReElement Technologies LLC ("ReElement"), a leading provider of high performance refining capacity of rare earth and critical battery elements, announced that it has received final approval for $46 million of local incentives from the City of Marion, Indiana in the form of an Economic Development Revenue Bond. This bond is being issued by the city as incentive for ReElement Technologies LLC to construct a state-of-the-art, commercial scale lithium, critical minerals, and rare earth elements refining facility utilizing ReElement Technologies' proprietary and patented chromatography technologies at the Company's recently announced 42-acre campus in Marion, Indiana.

 
Learn More
 

BioVie's Lead Drug Candidate Aims To Treat Neurodegenerative Disease By Targeting Inflammation

As researchers continue to hunt for better treatments for neurodegenerative disease, one of the biggest breakthroughs in decades has been the realization that chronic inflammation may be playing a key role in the onset and progression of debilitating diseases like Alzheimer's and Parkinson's disease. That's led biotechs like BioVie (NASDAQ:BIVI) to turn the focus to treatments that block or alter inflammation as a way to also stop the neurodegeneration causing the progressively worsening symptoms. NE3107, BioVie's lead drug candidate that modulates inflammation is now in late-stage clinical trials for Alzheimer's and Parkinson's disease.

 
Learn More
 

Genius Group Enters Joint Venture with Groove Digital and Groove AI to Deliver AI SAAS Platform to Educators

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, signed a joint venture partnership with Groove Digital Inc and Groove AI to deliver artificial-intelligence (“AI”) powered tools to GeniusU partners and faculty.

 
Learn More
 

 
 

Small Stocks Big Money™ Podcasts

Available on:


 
Learn More
 
 
 

Upcoming Events

3

October

2023

NASDAQ: RVSN - Rail Vision
11:00am Eastern
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry.
 
Sign Up
 

3

October

2023

NASDAQ: SPI - SPI Energy
4:15pm Eastern
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California.
 
Sign Up
 

4

October

2023

NASDAQ: STSS - Sharps Technology
4:15pm Eastern
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems.
 
Sign Up
 
 
 

Archive Events

21

September

2023

NYSE AMERICAN: SBEV - Splash Beverage Group
Meeting Duration 41 minutes
Splash Beverage Group is constantly innovating, presenting exciting, new, natural, and healthy drinks that delight the body and inspire the mind.
 
Watch Replay
 

20

September

2023

NASDAQ: RVPH - Reviva Pharmaceuticals Holdings
Meeting Duration 46 minutes
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.
 
Watch Replay
 
 
 

Lesson of the Week

The importance of leadership.

 
Learn More
 
 
 
 

RedChip TV

This Week on RedChip TV: Aridis Pharmaceuticals (OTC: ARDS) & Reviva Pharmaceuticals (NASDAQ: RVPH)

Sharps Technology: CEO Robert Hayes on Significant Commercialization Deal with Nephron

 
 

MidSouth Week in Review

For the month the S&P is down 4.1%, for a typical September return.

 
Learn More
 

You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
© 2023 RedChip , All rights reserved